Transense Technologies Balance Sheet Health
Financial Health criteria checks 6/6
Transense Technologies has a total shareholder equity of £5.6M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £6.5M and £897.0K respectively. Transense Technologies's EBIT is £1.3M making its interest coverage ratio -49.7. It has cash and short-term investments of £1.3M.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | -49.7x |
| Cash | UK£1.28m |
| Equity | UK£5.57m |
| Total liabilities | UK£897.00k |
| Total assets | UK£6.46m |
Recent financial health updates
No updates
Recent updates
We Think That There Are Some Issues For Transense Technologies (LON:TRT) Beyond Its Promising Earnings
Sep 30
Transense Technologies plc (LON:TRT) Surges 26% Yet Its Low P/E Is No Reason For Excitement
Aug 02Improved Earnings Required Before Transense Technologies plc (LON:TRT) Stock's 25% Jump Looks Justified
May 10Here's Why We Think Transense Technologies (LON:TRT) Might Deserve Your Attention Today
Sep 30Transense Technologies' (LON:TRT) Robust Earnings Are Not All Good News For Shareholders
Mar 02If EPS Growth Is Important To You, Transense Technologies (LON:TRT) Presents An Opportunity
Feb 09Transense Technologies plc (LON:TRT) Stock Rockets 37% But Many Are Still Ignoring The Company
Sep 28When Can We Expect A Profit From Transense Technologies plc (LON:TRT)?
May 12Analysts Expect Breakeven For Transense Technologies plc (LON:TRT) Before Long
Jan 05Financial Position Analysis
Short Term Liabilities: TRT's short term assets (£3.1M) exceed its short term liabilities (£593.0K).
Long Term Liabilities: TRT's short term assets (£3.1M) exceed its long term liabilities (£304.0K).
Debt to Equity History and Analysis
Debt Level: TRT is debt free.
Reducing Debt: TRT had no debt 5 years ago.
Debt Coverage: TRT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TRT has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 03:17 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Transense Technologies plc is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ian Jermin | Allenby Capital Limited |
| Sanjay Jha | Hybridan LLP |
| Pia Tapley | Singer Capital Markets |